<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02543489</url>
  </required_header>
  <id_info>
    <org_study_id>SJCR-OR-1103</org_study_id>
    <nct_id>NCT02543489</nct_id>
  </id_info>
  <brief_title>Flex Intramedullary Rod Study</brief_title>
  <official_title>A Prospective, Post-market, Multi-center Comparative Study of the Efficacy of Flex Intramedullary(IM) Rod in Terms of Range of Motion (ROM) Improvement.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Japan K.K.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Japan K.K.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effect of post-operative ROM between Flex IM rod
      and Rigid IM rod, to collect bone morphology of Japanese lower extremity and to research the
      incidence of overhung with Flex IM rod.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum postoperative flexion angle</measure>
    <time_frame>48 weeks after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life as assessed by36-Item Short-Form Health Survey (SF-36)questionnaire</measure>
    <time_frame>4 weeks , 24 weeks and 48 weeks after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Japanese Knee Osteoarthritis Measure(JKOM)</measure>
    <time_frame>4 weeks , 24 weeks and 48 weeks after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Society Scale (KSS)</measure>
    <time_frame>4 weeks , 24 weeks and 48 weeks after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion (ROM)</measure>
    <time_frame>4 weeks , 24 weeks and 48 weeks after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Osteoarthritis of the Knee</condition>
  <condition>Arthroplasty, Replacement, Knee</condition>
  <arm_group>
    <arm_group_label>Flex IM Rod</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Flex IM rod</intervention_name>
    <arm_group_label>Flex IM Rod</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient has signed an Institutional Review Board (IRB) approved, study specific
             Informed Patient Consent Form.

          2. Patient is a male or non-pregnant female age 20 years or older.

          3. Patient is candidate for primary Total Knee Arthroplasty (TKA).

          4. Patient whose preoperative range of motion (ROM) is over 110 degree.

          5. Patient is willing and able to comply with postoperative scheduled clinical and
             radiographic evaluations and rehabilitation.

        Exclusion Criteria:

          1. Revision cases

          2. Patients that use bone wedges or allograft due to bone loss.

          3. Patient has a Body Mass Index (BMI) &gt;40.

          4. Patient has an active or suspected latent infection in or about the affected knee
             joint at time of study device implantation.

          5. Patient has a neuromuscular or neurosensory deficiency, which limits the ability to
             evaluate the safety and efficacy of the device.

          6. Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic
             disorder (e.g. Paget's Disease) leading to progressive bone deterioration.

          7. Patient is immunologically suppressed or receiving steroids in excess of normal
             physiological requirements (e.g. &gt; 30 days).

          8. Patient has failed unicondylar knee prosthesis.

          9. Patient has a known sensitivity to device materials.

         10. Patient who are inappropriate for participating in the study in the judgment of the
             investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yasuyuki Inatsugu</last_name>
    <role>Study Director</role>
    <affiliation>Stryker Japan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hyogo College of Medicine Hospital</name>
      <address>
        <city>Nishinomiya</city>
        <state>Hyogo</state>
        <zip>663-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saiseikai Yokohama East Hospital</name>
      <address>
        <city>Yokohama</city>
        <state>Kanagawa</state>
        <zip>230-8765</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka General Medical Center</name>
      <address>
        <city>Osaka</city>
        <zip>558-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2015</study_first_submitted>
  <study_first_submitted_qc>September 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2015</study_first_posted>
  <last_update_submitted>November 7, 2016</last_update_submitted>
  <last_update_submitted_qc>November 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

